The Journal of Experimental & Clinical Cancer Research (JECCR) is a peer-reviewed, open access journal dedicated to advancing cancer research from basic discovery to clinical application. JECCR serves as a platform for the international community of cancer researchers, clinicians, and drug developers to share innovative findings and foster collaborative efforts towards better cancer prevention, diagnosis, and treatment. JECCR is committed to promoting rigorous scientific investigation and disseminating knowledge that will ultimately improve patient outcomes.
The scope of JECCR includes a broad range of topics related to cancer biology, experimental therapeutics, clinical trials, and translational research. Specific areas of interest include cancer genomics, tumor microenvironment, drug resistance, and immunotherapy. JECCR is indexed in major databases such as CAS, Scopus, PubMed, and Web of Science, ensuring wide dissemination and accessibility of its published research. JECCR is aimed at cancer biologists, oncologists, clinicians, and other researchers involved in the fight against cancer.
Submit your cutting-edge research to the Journal of Experimental & Clinical Cancer Research and contribute to the global effort to conquer cancer. JECCR is committed to providing a high-quality, open access platform for the dissemination of impactful research. By publishing in JECCR, you join a community of scientists dedicated to driving progress in cancer research and improving the lives of patients.